Background <p>Intraoperative ultrasound plays a central role in hepatobiliary surgery for the detection of liver lesions, but image interpretation is challenging and operator-dependent. Evidence supporting artificial intelligence-based detection tools in this setting remains limited. This study was designed as a preliminary pilot feasibility study of a future intraoperative support system for decision-making.</p> Methods <p>A retrospective dataset of 1,035 intraoperative ultrasound images containing malignant liver lesions was collected and manually annotated by an experienced hepatobiliary surgeon. Images were divided into a training set (<i>n</i> = 935) and a validation set (<i>n</i> = 100), comprising 114 lesions. Because this was an exploratory pilot study, all malignant lesions were analyzed as a single detection class. Three detection strategies were evaluated: a two-stage convolutional architecture (Cascade R-CNN), a single-stage detector (YOLO11), and a transformer-based model (RF-DETR). Performance was assessed using sensitivity, precision, and mean average precision (mAP).</p> Results <p>YOLO11 Medium achieved the highest sensitivity (63%), detecting 72 of 114 lesions while maintaining a precision of 62% and rapid offline inference. RF-DETR demonstrated the highest precision (80%) and superior localization accuracy (mAP@0.50 approximately 70%), with sensitivity close to 60%. Cascade R-CNN showed balanced but inferior performance compared with YOLO11 and RF-DETR.</p> Conclusion <p>Automated detection of malignant liver lesions in intraoperative ultrasound appears feasible in the preliminary pilot study. However, the observed sensitivity remains insufficient for autonomous intraoperative decision-making. YOLO11 and RF-DETR showed complementary strengths in sensitivity and precision, respectively, and should be regarded as exploratory support tools requiring further training, patient-level validation, and external multicenter evaluation before clinical implementation.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Pilot feasibility study of deep learning-based detection of malignant liver lesions in intraoperative ultrasound imaging

  • Pablo Parra-Méndez,
  • Pablo Parra-Membrives

摘要

Background

Intraoperative ultrasound plays a central role in hepatobiliary surgery for the detection of liver lesions, but image interpretation is challenging and operator-dependent. Evidence supporting artificial intelligence-based detection tools in this setting remains limited. This study was designed as a preliminary pilot feasibility study of a future intraoperative support system for decision-making.

Methods

A retrospective dataset of 1,035 intraoperative ultrasound images containing malignant liver lesions was collected and manually annotated by an experienced hepatobiliary surgeon. Images were divided into a training set (n = 935) and a validation set (n = 100), comprising 114 lesions. Because this was an exploratory pilot study, all malignant lesions were analyzed as a single detection class. Three detection strategies were evaluated: a two-stage convolutional architecture (Cascade R-CNN), a single-stage detector (YOLO11), and a transformer-based model (RF-DETR). Performance was assessed using sensitivity, precision, and mean average precision (mAP).

Results

YOLO11 Medium achieved the highest sensitivity (63%), detecting 72 of 114 lesions while maintaining a precision of 62% and rapid offline inference. RF-DETR demonstrated the highest precision (80%) and superior localization accuracy (mAP@0.50 approximately 70%), with sensitivity close to 60%. Cascade R-CNN showed balanced but inferior performance compared with YOLO11 and RF-DETR.

Conclusion

Automated detection of malignant liver lesions in intraoperative ultrasound appears feasible in the preliminary pilot study. However, the observed sensitivity remains insufficient for autonomous intraoperative decision-making. YOLO11 and RF-DETR showed complementary strengths in sensitivity and precision, respectively, and should be regarded as exploratory support tools requiring further training, patient-level validation, and external multicenter evaluation before clinical implementation.